AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Comparison of Operative Hysteroscopy and Vacuum Aspiration for Terminating First-trimester Pregnancy With Intrauterine Adhesions

Recruitingn/aAges 18 Years - 40 YearsFemaleWomen's Hospital School Of Medicine Zhejiang Univโ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

In cases of early pregnancy complicated with intrauterine adhesions (IUAs), termination of pregnancy is prone to incomplete abortion with retained gestational products, failed abortion or uterine perforation due to altered uterine cavity structure and gestational sac obscured by adhesive bands. Reoperation may even be required, which increases the risk of surgical trauma, as well as the psychological and financial burdens on patients. Meanwhile, some patients with IUAs still have fertility demands in the future, so the adhesions also need to be addressed. Hysteroscopy allows direct visualization to remove intrauterine gestational contents, lowering the risks of tissue retention and reoperation. It also enables concurrent treatment of existing IUAs. Combined with postoperative interventions to prevent adhesion recurrence, this approach can restore the uterine cavity structure and endomet

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. patients with transvaginal ultrasound findings suggestive of IUA; 2. patients who underwent follow-up postoperative ultrasound examinations for 3 or more months at the study hospital; 3. patients with a desire to bear children; 4. patients with no significant organic diseases. Exclusion Criteria: 1. patients with ectopic pregnancies, e.g., a cesarean scar pregnancy, angular pregnancies, or a cervical pregnancy; 2. patients who underwent other intrauterine surgical procedures, such as endometrial polypectomy, submucosal myomectomy, or uterine septum resection, during hysteroscopy; 3. patients who underwent medical termination of pregnancy with oral mifepristone plus misoprostol without surgery; 4. patients with abnormal postoperative pathological results, e.g., molar pregnancy; 5. patients without follow-up data or ultrasound results or with incomplete data for 3 months after surgery; 6. patients whose initial surgery was not performed at the study hospital.
๐Ÿ’Š

What it tests

  • Vacuum Aspiration Group
  • Hysteroscopy adhesiolysis combined with vacuum aspiration
๐Ÿ“

Where

1 site
Women's Hospital, Zhejiang University School of Medicine
Hangzhou, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy